Subscribe to RSS
DOI: 10.1055/a-2284-9622
Impact of a new dedicated sheath device for tissue sampling of biliary stricture on pathological diagnostic yield: Retrospective study
Abstract
Background and study aims Endoscopic transpapillary biliary forceps biopsy (TBFB) is a common method for obtaining specimens from biliary lesions. Its diagnostic yield is unsatisfactory; to overcome this disadvantage, a dedicated sheath has been developed. This study aimed to evaluate the outcomes of conventional TBFB and TBFB with a novel sheath device.
Patients and methods Consecutive patients who underwent TBFB between January 2020 and December 2021 were retrospectively evaluated. The rate of obtaining adequate samples, failed attempts at forceps insertion into the bile duct, and sensitivity were compared between the two groups.
Results Ninety-two patients who underwent 115 endoscopic retrograde cholangiopancreatographies (76 in the conventional group vs. 39 in the dedicated sheath group) were included. The rates of obtaining adequate samples, failed attempts of the forceps into the bile duct, and sensitivity were 72.4% vs. 89.7% (P = 0.03), 28.3% vs. 0% (P < 0.01), and 66.7% vs. 88.9% (P = 0.02), respectively.
Conclusions TBFB with the novel sheath device contributed to improved sensitivity for diagnosis of biliary stricture without insertion of forceps outside the bile duct.
Publication History
Received: 05 November 2023
Accepted after revision: 23 February 2024
Accepted Manuscript online:
11 March 2024
Article published online:
15 April 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Rustgi AK, Kelsey PB, Guelrud M. et al. Malignant tumors of the bile ducts: diagnosis by biopsy during endoscopic cannulation. Gastrointest Endosc 1989; 35: 248-251
- 2 De Bellis M, Sherman S, Fogel EL. et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc 2002; 56: 552-561 DOI: 10.1067/mge.2002.129219. (PMID: 12397282)
- 3 Burnett AS, Calvert TJ, Chokshi RJ. Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature. J Surg Res 2013; 184: 304-311 DOI: 10.1016/j.jss.2013.06.028. (PMID: 23866788)
- 4 Nanda A, Brown JM, Berger SH. et al. Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma. Ther Adv Gastroenterol 2015; 8: 56-65 DOI: 10.1177/1756283X14564674. (PMID: 25729431)
- 5 Navaneethan U, Njei B, Lourdusamy V. et al. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc 2015; 81: 168-176 DOI: 10.1016/j.gie.2014.09.017. (PMID: 25440678)
- 6 Kawashima H, Itoh A, Ohno E. et al. Transpapillary biliary forceps biopsy to distinguish benign biliary stricture from malignancy: how many tissue samples should be obtained?. Dig Endosc 2012; 24: 22-27
- 7 Ikeda M, Maetani I, Terada K. et al. Usefulness of endoscopic retrograde biliary biopsy using large-capacity forceps for extrahepatic biliary strictures: a prospective randomized study. Endoscopy 2010; 42: 837-841 DOI: 10.1055/s-0030-1255633. (PMID: 20886402)
- 8 ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA. et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32-47
- 9 ASGE Standards of Practice Committee, Anderson MA, Fisher L. et al. Complications of ERCP. Gastrointest Endosc 2012; 75: 467-473
- 10 Dumonceau JM, Kapral C, Aabakken L. et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2020; 52: 127-149 DOI: 10.1055/a-1075-4080. (PMID: 31863440)
- 11 Hijioka S, Hara K, Mizuno N. et al. A novel technique for endoscopic transpapillary “mapping biopsy specimens” of superficial intraductal spread of bile duct carcinoma (with videos). Gastrointest Endosc 2014; 79: 1020-1025
- 12 Matsumori T, Uza N, Shiokawa M. et al. Clinical impact of a novel device delivery system in the diagnosis of bile duct lesions: A single-center experience. J Gastroenterol Hepatol 2022; 37: 1360-1366 DOI: 10.1111/jgh.15866. (PMID: 35434844)
- 13 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454 DOI: 10.1016/j.gie.2009.10.027. (PMID: 20189503)
- 14 Okada H, Uza N, Matsumori T. et al. A novel technique for mapping biopsy of bile duct cancer. Endoscopy 2021; 53: 647-651 DOI: 10.1055/a-1248-2138. (PMID: 32961577)
- 15 Ko SW, Lee SS, So H. et al. A novel method of biopsy for indeterminate pancreaticobiliary strictures: tube-assisted biopsy. Endoscopy 2020; 52: 589-594 DOI: 10.1055/a-1127-3265. (PMID: 32219796)
- 16 Verlingue L, Malka D, Allorant A. et al. Precision medicine for patients with advanced biliary tract cancers: an effective strategy within the prospective MOSCATO-01 trial. Eur J Cancer 2017; 87: 122-130
- 17 Yang MJ, Hwang JC, Lee D. et al. Factors affecting the diagnostic yield of endoscopic transpapillary forceps biopsy in patients with malignant biliary strictures. J Gastroenterol Hepatol 2021; 36: 2324-2328